A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms
Clinical trial NCT01550926 · COMPLETED
Trial details
- NCT number
- NCT01550926
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2009-03-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.